Fortrea Executive and Leadership Team

Mark Morais, the Clinical Services Chief Operating Officer & President at Fortrea, directs the execution of global clinical trial programs. Overseeing the integration of research facilities across North America and Europe, Morais ensures operational excellence within the clinical development lifecycle. This leadership role involves managing complex R&D service delivery while maintaining strict scientific rigor. By optimizing resource allocation across specialized teams, Morais drives efficiency in the transition from medical concepts to viable therapies. The Clinical Services Chief Operating Officer & President collaborates with the board to align operational capacity with the evolving needs of the pharmaceutical industry. Through the implementation of standardized protocols, Mark Morais enhances the speed and reliability of clinical research. Ultimately, Morais secures the operational foundation necessary for delivering high-quality data to clients, ensuring that every trial meets the highest standards of safety and regulatory compliance in the global healthcare market.

Oren Cohen, the Chief Medical Officer and President, Clinical Pharmacology Services at Fortrea, leads the scientific strategy for early-phase clinical trials. Overseeing the clinical pharmacology division, Cohen ensures that all research activities adhere to the highest standards of medical excellence and scientific rigor. This leadership role involves guiding the development of innovative therapies through complex regulatory landscapes. By directing the medical oversight of trials, the Chief Medical Officer and President, Clinical Pharmacology Services ensures that patient safety remains the primary focus during the research process. Oren Cohen collaborates with global healthcare partners to translate promising medical ideas into proven clinical outcomes. Through the management of specialized medical teams, Cohen drives the strategic direction of pharmacology services across international markets. Ultimately, the Chief Medical Officer and President, Clinical Pharmacology Services maintains the scientific integrity of the organization, ensuring that every clinical development program benefits from deep medical expertise and precise, evidence-based problem-solving.

Ding Ming, the Fortrea President & General Manager (China) at Fortrea, directs all clinical research operations and business development initiatives within the Asia Pacific region. Overseeing the expansion of research facilities, Ming ensures that the company maintains a competitive presence in the rapidly evolving Chinese pharmaceutical market. This leadership role involves navigating local regulatory complexities while aligning regional activities with the global mission of the organization. By fostering strategic partnerships with local biotechnology firms, the Fortrea President & General Manager (China) drives growth and operational efficiency. Ding Ming manages the specialized teams responsible for executing clinical trials, ensuring that every project meets the rigorous standards required for global drug development. Through the coordination of regional resources, Ming enhances the company's ability to deliver comprehensive research solutions. Ultimately, the Fortrea President & General Manager (China) secures the long-term success of the organization by bridging local market opportunities with the broader, global clinical development capabilities.

Madeshwaran Rajendran, the Chief Information Officer, Information Technology Vendor Management-Office at Fortrea, architects the digital infrastructure supporting global clinical research. Overseeing the management of technology vendors, Rajendran ensures that all software and data systems align with the rigorous demands of the biotechnology sector. This leadership role involves securing the integrity of clinical data across the extensive network of research facilities in Africa and South America. By streamlining IT procurement and vendor partnerships, the Chief Information Officer, Information Technology Vendor Management-Office optimizes the technological backbone of the organization. Madeshwaran Rajendran drives innovation by integrating advanced analytics into the clinical development process, facilitating faster decision-making for research teams. Through the oversight of complex digital ecosystems, Rajendran maintains the security and scalability of the company's information assets. Ultimately, the Chief Information Officer, Information Technology Vendor Management-Office provides the technical stability required to support the entire clinical development process.